Suchergebnisse

Intro -- Table of Contents -- Acknowledgments -- Introduction -- Part I: The Setting -- 1. A World of Empires -- 2. Destiny and Dollars -- 3. Evolution of the New Imperialism: The Philippines -- 4. James Harrison Wilson: A Transitional Expansionist -- Part II: The Matrices -- 5. The Tone of Society -- 6. Theodore Roosevelt and the Sturdy Virtues -- 7. Civilization, Barbarism, and Christianity -- 8. Elihu Root: A World of Order and Progress -- 9. Commercial Domination -- 10. Charles Denby: The China Market -- 11. Charles A. Conant: The Implications of Commercial Struggle -- Part III: The Issues -- 12. The Anti-Imperialist Movement -- 13. Conflict and Consensus -- Conclusion -- Notes -- Bibliography -- Index.

"This searing indictment, David Healy's most comprehensive and forceful argument against the pharmaceuticalization of medicine, tackles problems in health care that are leading to a growing number of deaths and disabilities. Healy, who was the first to draw attention to the now well-publicized suicide-inducing side effects of many anti-depressants, attributes our current state of affairs to three key factors: product rather than process patents on drugs, the classification of certain drugs as prescription-only, and industry-controlled drug trials. These developments have tied the survival of pharmaceutical companies to the development of blockbuster drugs, so that they must overhype benefits and deny real hazards. Healy further explains why these trends have basically ended the possibility of universal health care in the United States and elsewhere around the world. He concludes with suggestions for reform of our currently corrupted evidence-based medical system"--Provided by publisher.

Intro -- CONTENTS -- INTRODUCTION -- Who Was James G. Blaine? -- Guatemala and Mexico -- The Isthmian Canal -- The War of the Pacific, I -- The War of the Pacific, II -- Blaine at Bay -- Seven Years Out of Office -- The Inter-American Conference -- Tariff Reciprocity -- Caribbean Naval Bases -- The Chilean Crisis, I -- The Chilean Crisis, II -- Conclusion -- BIBLIOGRAPHY -- INDEX.

This article considers the dominance that randomized controlled trials (RCTs) of psychotropic agents currently have in relation to the practice of psychiatry in mental health and primary care settings. In contemporary psychiatry, data of marginal significance based on rating scale measures are privileged as evidence that treatments are effective, while judgments of drug effects based on clinical practice are downgraded. The dominance of RCTs has also led to an increasing promotion of rating scales in clinical practice, described here as `rating scale mongering.' The logical consequence of current interpretations of RCT data is that clinicians should adhere to guidelines which are based on a systematic assembly of such data, but the selective publication of trial data and ghostwriting of publications, lays the basis for guideline capture, and a corresponding capture of evidence-based clinical practice by pharmaceutical companies.